Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease

INTRODUCTION: The safety and efficacy of exenatide once weekly (EQW) is overall well established. EQW is primarily renally eliminated. In this study, the efficacy and renal and gastrointestinal tolerability of EQW were summarised in participants with type 2 diabetes and chronic kidney disease stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Guja, Cristian, Frías, Juan P., Suchower, Lisa, Hardy, Elise, Marr, Galina, Sjöström, C. David, Jabbour, Serge A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324446/
https://www.ncbi.nlm.nih.gov/pubmed/32306296
http://dx.doi.org/10.1007/s13300-020-00815-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324446/
https://www.ncbi.nlm.nih.gov/pubmed/32306296
http://dx.doi.org/10.1007/s13300-020-00815-z

Ejemplares similares